{"id":"W2732470776","doi":"10.1093/annonc/mdx302.002","title":"Phase 1b/II study of cancer stemness inhibitor napabucasin in combination with FOLFIRI +/− bevacizumab (bev) in metastatic colorectal cancer (mCRC) patients (pts)","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bioactive Compounds and Antitumor Agents","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; FOLFIRI; Internal medicine; Cancer; Colorectal cancer; Gastroenterology; Oncology; Combination therapy; Irinotecan","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007494997,0.001442133,0.002585337,0.0004401919,0.0003576795,0.001002092,0.0007490437,0.001041342,0.004358414],"category_scores_gemma":[0.0005013816,0.0007266853,0.001531855,0.0004008328,0.0009305692,0.0008713503,0.000316711,0.003298153,0.0009583771],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009987615,"about_ca_system_score_gemma":0.00140692,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001698709,"about_ca_topic_score_gemma":0.005513974,"domain_scores_codex":[0.999801,0.00005995702,0.000008623208,0.00004896948,0.00001688761,0.00006458475],"domain_scores_gemma":[0.9996951,0.00003066007,0.00004369139,0.00002452134,0.00001987633,0.0001861143],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7833893,0.06512892,0.003163117,0.001132584,0.001793249,0.0001835555,0.0002418953,0.00244427,0.04303622,0.0004177946,0.005198546,0.09387062],"study_design_scores_gemma":[0.5753409,0.4088702,0.006368017,0.00004625269,0.0007907765,0.0001840762,0.00007835857,0.0009348635,0.003446726,0.0002623594,0.003646224,0.00003111341],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.989815,0.003655065,0.0005241091,0.000643454,0.0002663331,0.002003117,0.001151923,0.0001395356,0.001801603],"genre_scores_gemma":[0.9824091,0.004346122,0.001831642,0.0009781226,0.0001971961,0.002132439,0.002743716,0.00004554574,0.005316039],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004358414,"threshold_uncertainty_score":0.01458031,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2443052311328311,"score_gpt":0.5327082909976887,"score_spread":0.2884030598648576,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}